Using apolipoprotein B to manage dyslipidemia. - Wikidata - wikimedia - TriplyDB

Using apolipoprotein B to manage dyslipidemia.

Using apolipoprotein B to manage dyslipidemia.

http://www.wikidata.org/entity/Q42638981

about

Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study.

P2860

Q24626884-6CE0B174-6D01-430C-8CF2-B373A6A671C0 Q39383777-51D6EB5B-66AE-41F5-9F73-B0316D1829BB

P2860

Using apolipoprotein B to manage dyslipidemia.

http://www.wikidata.org/entity/Q42638981

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Using apolipoprotein B to manage dyslipidemia.

@en

Using apolipoprotein B to manage dyslipidemia.

@nl

type

label

Using apolipoprotein B to manage dyslipidemia.

@en

Using apolipoprotein B to manage dyslipidemia.

@nl

prefLabel

Using apolipoprotein B to manage dyslipidemia.

@en

Using apolipoprotein B to manage dyslipidemia.

@nl

P1433

Q42638981-02703042-98A7-4FB5-AE0E-512F44851896

P1476

Q42638981-593CB995-9722-4F09-8E04-178F44C6821D

P2093

Q42638981-A1C8B8A2-0840-4A26-A7F8-2BA2524CA5C3

P2860

Q42638981-063C2175-D814-4564-A69D-91ADA4A80D52

Q42638981-16D56957-BADE-4EBD-A617-0D4CE05A31FF

Q42638981-46650956-C283-4F51-A569-6766E3BA78BE

Q42638981-853D2C93-C7E7-4205-8FFD-AFA3EC05998B

Q42638981-875FD7E5-1E88-417B-91E0-9219629FE6EB

P304

Q42638981-AD304E04-BD5A-435F-99FA-43162FB32B58

P31

Q42638981-3EDC3D98-53B3-46BC-8BF6-BCB8C7F3AAFE

P356

Q42638981-BF54D9FC-442D-4769-B123-B0F51D892415

P407

Q42638981-6E1B69BA-F89C-48DC-8452-566B87428088

P433

Q42638981-69DE7804-6EBD-4B96-BFCC-4F9557855AE1

P478

Q42638981-63C03B14-1BF1-4663-A134-9F6EBA7FD93D

P577

Q42638981-CF429297-C5B8-485A-8B92-D475A7356F88

P5875

Q42638981-C03E2FE2-F6A1-48BC-A927-26328D71BEC0

P698

Q42638981-A4C5A940-9A75-4F8D-B16E-E05AF29CB73E

P921

Q42638981-DC358F3B-2225-4B36-8400-B19D294112B7

P932

Q42638981-96030433-53B0-4297-9740-7C38A93963C0

P356

P1433

Mayo Clinic Proceedings

P1476

Using apolipoprotein B to manage dyslipidemia.

@en

P2093

Jennifer G Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY

Using apolipoprotein B to manage dyslipidemic patients: time for a change?

To B or not to B: is non-high-density lipoprotein cholesterol an adequate surrogate for apolipoprotein B?

Major lipids, apolipoproteins, and risk of vascular disease.

Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.

P304

769; author reply 769-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4065/MCP.2010.0287

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45440385

http://www.w3.org/2001/XMLSchema#string

P698

20675517

http://www.w3.org/2001/XMLSchema#string

P921

P932

2912744

http://www.w3.org/2001/XMLSchema#string